Treatments for Lennox-Gastaut syndrome
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (7)
- FinteplafenfluramineUCB, Inc.Approved Mar 2022
- EpidiolexCANNABIDIOLJazz Pharmaceuticals, Inc.Approved Sep 2018
- OnficlobazamLundbeck, Inc.Approved Oct 2011
- BanzelrufinamideEisai, Inc.Approved Nov 2008
- TopamaxTopiramateJohnson & Johnson Pharmaceutical R & D, LLCApproved Aug 2001
- LamictalLamotrigineGlaxo Wellcome Research and DevelopmentApproved Aug 1998
- FelbamateFELBAMATETaro Pharmaceuticals U.S.A., Inc.Approved Jul 1993
Patient support programs (5)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
Onfi
Lundbeck
Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
Epidiolex
Jazz Pharmaceuticals, Inc.
Epidiolex Patient Support (JazzCares)
Patient Assistance
Manufacturer Program
Accepting applications
Lamictal
Glaxo Wellcome Research and Development
Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications
Banzel
Eisai, Inc.
Banzel — Contact Eisai, Inc.
Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications
Fintepla
UCB, Inc.
Fintepla Patient Support (UCB Patient Assistance)
Patient Assistance
Manufacturer Program
Accepting applications